Patienter bør monitoreres omhyggeligt for mulig lægemiddeltoksicitet og/ eller behandlingssvigt ved samtidig administration af voriconazol og HIV- proteasehæmmere.
Patients should be carefully monitored for any occurrence of drug toxicity and/ or loss of efficacy during the co-administration of voriconazole and HIV protease inhibitors.